High prevalence of high‐risk HPV genotypes in individuals attending an infectious diseases clinic from 2018 to 2022 in Milan, Italy

Human papillomavirus (HPV) is the most common sexually transmitted infection, linked to several types of lesions. HPV, specifically HPV 16, accounts for most of anal cancer cases. In this study, we evaluated the proportion of samples tested positive for HPV and characterized genotypes distribution i...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of medical virology 2024-01, Vol.96 (1), p.e29370-n/a
Hauptverfasser: Rizzo, Alberto, Moschese, Davide, Salari, Federica, Giacomelli, Andrea, Morelli, Loriana, Cossu, Maria Vittoria, Fusetti, Chiara, Petri, Francesco, Casalini, Giacomo, Poloni, Andrea, Lazzarin, Samuel, Gori, Andrea, Antinori, Spinello, Gismondo, Maria Rita, Lombardi, Alessandra, Rizzardini, Giuliano
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page n/a
container_issue 1
container_start_page e29370
container_title Journal of medical virology
container_volume 96
creator Rizzo, Alberto
Moschese, Davide
Salari, Federica
Giacomelli, Andrea
Morelli, Loriana
Cossu, Maria Vittoria
Fusetti, Chiara
Petri, Francesco
Casalini, Giacomo
Poloni, Andrea
Lazzarin, Samuel
Gori, Andrea
Antinori, Spinello
Gismondo, Maria Rita
Lombardi, Alessandra
Rizzardini, Giuliano
description Human papillomavirus (HPV) is the most common sexually transmitted infection, linked to several types of lesions. HPV, specifically HPV 16, accounts for most of anal cancer cases. In this study, we evaluated the proportion of samples tested positive for HPV and characterized genotypes distribution in anal specimens collected from individuals at risk of anal HPV infection attending from 2018 to 2022 a large Infectious Diseases Department in Italy. The presence of HPV DNA was investigated through a commercial kit detecting 12 HR‐HPV, 8 probable/possible HR‐HPV, and 8 LR‐HPV genotypes. Among 1514 samples, 84% (1266/1514) resulted positive for any type of HPV. The prevalence of high‐risk HPV types remained high during all the years of the study period, from 2018 to 2022, ranging from 65% to 73%. Most of HR‐HPV, LR‐HPV and HPV 16 positive samples were collected from men >45 years. HPV 16 was also the most frequent type in men and women. We did not observe significant variations between years in detection of HR‐HPV, instead of LR‐HPV, that significantly decreased. In conclusion, the high prevalence of oncogenic HPV genotypes underlines the necessity of clear anal HPV screening guidelines and, along with frequent HR‐HPV coinfections, reinforces the urge to intensify the anti‐HPV vaccination campaign.
doi_str_mv 10.1002/jmv.29370
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2913081827</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2913081827</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3530-f6119d9756991df517ad735abfc3f7df479c52f4d60479995b9e0c13f45568383</originalsourceid><addsrcrecordid>eNp1kUtLXDEYhoO01Kl24R8oATcKHs2XTJKTpUjtWBRdtG4PmVzGTM9lTM6ZMrtuuu9v7C8xp2NdCA2BL5eHhxdehA6AnAIh9GzZrE-pYpLsoAkQJQpFJLxBEwJTUQgBfBe9T2lJCCkVpe_QLitBSQ7lBP2ahcUDXkW31rVrjcOdxw_56c_P3zGk73h2d48Xru36zcolHNq8bVgHO-g6Yd33Ll_bBdbjh3emD92QsA3J6ZR5U4c2GOxj12BKoMR9lyelo-gm1Lo9wVe9rjf76K3PQvfhee6hb5efvl7Miuvbz1cX59eFYZyRwgsAZXNyoRRYz0FqKxnXc2-Yl9ZPpTKc-qkVJB-V4nPliAHmp5yLkpVsDx1tvavYPQ4u9VUTknF1TuJy8IoqYKSEksqMHr5Cl90Q25xupGReQo3U8ZYysUspOl-tYmh03FRAqrGbKndT_e0msx-fjcO8cfaF_FdGBs62wI9Qu83_TdWXm_ut8gmeL5eo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2917777697</pqid></control><display><type>article</type><title>High prevalence of high‐risk HPV genotypes in individuals attending an infectious diseases clinic from 2018 to 2022 in Milan, Italy</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Rizzo, Alberto ; Moschese, Davide ; Salari, Federica ; Giacomelli, Andrea ; Morelli, Loriana ; Cossu, Maria Vittoria ; Fusetti, Chiara ; Petri, Francesco ; Casalini, Giacomo ; Poloni, Andrea ; Lazzarin, Samuel ; Gori, Andrea ; Antinori, Spinello ; Gismondo, Maria Rita ; Lombardi, Alessandra ; Rizzardini, Giuliano</creator><creatorcontrib>Rizzo, Alberto ; Moschese, Davide ; Salari, Federica ; Giacomelli, Andrea ; Morelli, Loriana ; Cossu, Maria Vittoria ; Fusetti, Chiara ; Petri, Francesco ; Casalini, Giacomo ; Poloni, Andrea ; Lazzarin, Samuel ; Gori, Andrea ; Antinori, Spinello ; Gismondo, Maria Rita ; Lombardi, Alessandra ; Rizzardini, Giuliano</creatorcontrib><description>Human papillomavirus (HPV) is the most common sexually transmitted infection, linked to several types of lesions. HPV, specifically HPV 16, accounts for most of anal cancer cases. In this study, we evaluated the proportion of samples tested positive for HPV and characterized genotypes distribution in anal specimens collected from individuals at risk of anal HPV infection attending from 2018 to 2022 a large Infectious Diseases Department in Italy. The presence of HPV DNA was investigated through a commercial kit detecting 12 HR‐HPV, 8 probable/possible HR‐HPV, and 8 LR‐HPV genotypes. Among 1514 samples, 84% (1266/1514) resulted positive for any type of HPV. The prevalence of high‐risk HPV types remained high during all the years of the study period, from 2018 to 2022, ranging from 65% to 73%. Most of HR‐HPV, LR‐HPV and HPV 16 positive samples were collected from men &gt;45 years. HPV 16 was also the most frequent type in men and women. We did not observe significant variations between years in detection of HR‐HPV, instead of LR‐HPV, that significantly decreased. In conclusion, the high prevalence of oncogenic HPV genotypes underlines the necessity of clear anal HPV screening guidelines and, along with frequent HR‐HPV coinfections, reinforces the urge to intensify the anti‐HPV vaccination campaign.</description><identifier>ISSN: 0146-6615</identifier><identifier>ISSN: 1096-9071</identifier><identifier>EISSN: 1096-9071</identifier><identifier>DOI: 10.1002/jmv.29370</identifier><identifier>PMID: 38197518</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>anal canal ; Female ; Genotype ; Genotypes ; HIV ; HPV ; HPV 16 ; Human papillomavirus ; Human papillomavirus 16 ; Humans ; Infectious diseases ; Italy - epidemiology ; Male ; Medical screening ; Papillomavirus Infections - epidemiology ; Prevalence ; Risk ; Sexually transmitted diseases ; STD ; STI ; Vaccination ; Virology</subject><ispartof>Journal of medical virology, 2024-01, Vol.96 (1), p.e29370-n/a</ispartof><rights>2024 Wiley Periodicals LLC.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3530-f6119d9756991df517ad735abfc3f7df479c52f4d60479995b9e0c13f45568383</citedby><cites>FETCH-LOGICAL-c3530-f6119d9756991df517ad735abfc3f7df479c52f4d60479995b9e0c13f45568383</cites><orcidid>0000-0003-3685-4289 ; 0000-0003-0740-5361 ; 0000-0001-5999-006X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fjmv.29370$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fjmv.29370$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>315,782,786,1419,27933,27934,45583,45584</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38197518$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rizzo, Alberto</creatorcontrib><creatorcontrib>Moschese, Davide</creatorcontrib><creatorcontrib>Salari, Federica</creatorcontrib><creatorcontrib>Giacomelli, Andrea</creatorcontrib><creatorcontrib>Morelli, Loriana</creatorcontrib><creatorcontrib>Cossu, Maria Vittoria</creatorcontrib><creatorcontrib>Fusetti, Chiara</creatorcontrib><creatorcontrib>Petri, Francesco</creatorcontrib><creatorcontrib>Casalini, Giacomo</creatorcontrib><creatorcontrib>Poloni, Andrea</creatorcontrib><creatorcontrib>Lazzarin, Samuel</creatorcontrib><creatorcontrib>Gori, Andrea</creatorcontrib><creatorcontrib>Antinori, Spinello</creatorcontrib><creatorcontrib>Gismondo, Maria Rita</creatorcontrib><creatorcontrib>Lombardi, Alessandra</creatorcontrib><creatorcontrib>Rizzardini, Giuliano</creatorcontrib><title>High prevalence of high‐risk HPV genotypes in individuals attending an infectious diseases clinic from 2018 to 2022 in Milan, Italy</title><title>Journal of medical virology</title><addtitle>J Med Virol</addtitle><description>Human papillomavirus (HPV) is the most common sexually transmitted infection, linked to several types of lesions. HPV, specifically HPV 16, accounts for most of anal cancer cases. In this study, we evaluated the proportion of samples tested positive for HPV and characterized genotypes distribution in anal specimens collected from individuals at risk of anal HPV infection attending from 2018 to 2022 a large Infectious Diseases Department in Italy. The presence of HPV DNA was investigated through a commercial kit detecting 12 HR‐HPV, 8 probable/possible HR‐HPV, and 8 LR‐HPV genotypes. Among 1514 samples, 84% (1266/1514) resulted positive for any type of HPV. The prevalence of high‐risk HPV types remained high during all the years of the study period, from 2018 to 2022, ranging from 65% to 73%. Most of HR‐HPV, LR‐HPV and HPV 16 positive samples were collected from men &gt;45 years. HPV 16 was also the most frequent type in men and women. We did not observe significant variations between years in detection of HR‐HPV, instead of LR‐HPV, that significantly decreased. In conclusion, the high prevalence of oncogenic HPV genotypes underlines the necessity of clear anal HPV screening guidelines and, along with frequent HR‐HPV coinfections, reinforces the urge to intensify the anti‐HPV vaccination campaign.</description><subject>anal canal</subject><subject>Female</subject><subject>Genotype</subject><subject>Genotypes</subject><subject>HIV</subject><subject>HPV</subject><subject>HPV 16</subject><subject>Human papillomavirus</subject><subject>Human papillomavirus 16</subject><subject>Humans</subject><subject>Infectious diseases</subject><subject>Italy - epidemiology</subject><subject>Male</subject><subject>Medical screening</subject><subject>Papillomavirus Infections - epidemiology</subject><subject>Prevalence</subject><subject>Risk</subject><subject>Sexually transmitted diseases</subject><subject>STD</subject><subject>STI</subject><subject>Vaccination</subject><subject>Virology</subject><issn>0146-6615</issn><issn>1096-9071</issn><issn>1096-9071</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kUtLXDEYhoO01Kl24R8oATcKHs2XTJKTpUjtWBRdtG4PmVzGTM9lTM6ZMrtuuu9v7C8xp2NdCA2BL5eHhxdehA6AnAIh9GzZrE-pYpLsoAkQJQpFJLxBEwJTUQgBfBe9T2lJCCkVpe_QLitBSQ7lBP2ahcUDXkW31rVrjcOdxw_56c_P3zGk73h2d48Xru36zcolHNq8bVgHO-g6Yd33Ll_bBdbjh3emD92QsA3J6ZR5U4c2GOxj12BKoMR9lyelo-gm1Lo9wVe9rjf76K3PQvfhee6hb5efvl7Miuvbz1cX59eFYZyRwgsAZXNyoRRYz0FqKxnXc2-Yl9ZPpTKc-qkVJB-V4nPliAHmp5yLkpVsDx1tvavYPQ4u9VUTknF1TuJy8IoqYKSEksqMHr5Cl90Q25xupGReQo3U8ZYysUspOl-tYmh03FRAqrGbKndT_e0msx-fjcO8cfaF_FdGBs62wI9Qu83_TdWXm_ut8gmeL5eo</recordid><startdate>202401</startdate><enddate>202401</enddate><creator>Rizzo, Alberto</creator><creator>Moschese, Davide</creator><creator>Salari, Federica</creator><creator>Giacomelli, Andrea</creator><creator>Morelli, Loriana</creator><creator>Cossu, Maria Vittoria</creator><creator>Fusetti, Chiara</creator><creator>Petri, Francesco</creator><creator>Casalini, Giacomo</creator><creator>Poloni, Andrea</creator><creator>Lazzarin, Samuel</creator><creator>Gori, Andrea</creator><creator>Antinori, Spinello</creator><creator>Gismondo, Maria Rita</creator><creator>Lombardi, Alessandra</creator><creator>Rizzardini, Giuliano</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7TK</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-3685-4289</orcidid><orcidid>https://orcid.org/0000-0003-0740-5361</orcidid><orcidid>https://orcid.org/0000-0001-5999-006X</orcidid></search><sort><creationdate>202401</creationdate><title>High prevalence of high‐risk HPV genotypes in individuals attending an infectious diseases clinic from 2018 to 2022 in Milan, Italy</title><author>Rizzo, Alberto ; Moschese, Davide ; Salari, Federica ; Giacomelli, Andrea ; Morelli, Loriana ; Cossu, Maria Vittoria ; Fusetti, Chiara ; Petri, Francesco ; Casalini, Giacomo ; Poloni, Andrea ; Lazzarin, Samuel ; Gori, Andrea ; Antinori, Spinello ; Gismondo, Maria Rita ; Lombardi, Alessandra ; Rizzardini, Giuliano</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3530-f6119d9756991df517ad735abfc3f7df479c52f4d60479995b9e0c13f45568383</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>anal canal</topic><topic>Female</topic><topic>Genotype</topic><topic>Genotypes</topic><topic>HIV</topic><topic>HPV</topic><topic>HPV 16</topic><topic>Human papillomavirus</topic><topic>Human papillomavirus 16</topic><topic>Humans</topic><topic>Infectious diseases</topic><topic>Italy - epidemiology</topic><topic>Male</topic><topic>Medical screening</topic><topic>Papillomavirus Infections - epidemiology</topic><topic>Prevalence</topic><topic>Risk</topic><topic>Sexually transmitted diseases</topic><topic>STD</topic><topic>STI</topic><topic>Vaccination</topic><topic>Virology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rizzo, Alberto</creatorcontrib><creatorcontrib>Moschese, Davide</creatorcontrib><creatorcontrib>Salari, Federica</creatorcontrib><creatorcontrib>Giacomelli, Andrea</creatorcontrib><creatorcontrib>Morelli, Loriana</creatorcontrib><creatorcontrib>Cossu, Maria Vittoria</creatorcontrib><creatorcontrib>Fusetti, Chiara</creatorcontrib><creatorcontrib>Petri, Francesco</creatorcontrib><creatorcontrib>Casalini, Giacomo</creatorcontrib><creatorcontrib>Poloni, Andrea</creatorcontrib><creatorcontrib>Lazzarin, Samuel</creatorcontrib><creatorcontrib>Gori, Andrea</creatorcontrib><creatorcontrib>Antinori, Spinello</creatorcontrib><creatorcontrib>Gismondo, Maria Rita</creatorcontrib><creatorcontrib>Lombardi, Alessandra</creatorcontrib><creatorcontrib>Rizzardini, Giuliano</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of medical virology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rizzo, Alberto</au><au>Moschese, Davide</au><au>Salari, Federica</au><au>Giacomelli, Andrea</au><au>Morelli, Loriana</au><au>Cossu, Maria Vittoria</au><au>Fusetti, Chiara</au><au>Petri, Francesco</au><au>Casalini, Giacomo</au><au>Poloni, Andrea</au><au>Lazzarin, Samuel</au><au>Gori, Andrea</au><au>Antinori, Spinello</au><au>Gismondo, Maria Rita</au><au>Lombardi, Alessandra</au><au>Rizzardini, Giuliano</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>High prevalence of high‐risk HPV genotypes in individuals attending an infectious diseases clinic from 2018 to 2022 in Milan, Italy</atitle><jtitle>Journal of medical virology</jtitle><addtitle>J Med Virol</addtitle><date>2024-01</date><risdate>2024</risdate><volume>96</volume><issue>1</issue><spage>e29370</spage><epage>n/a</epage><pages>e29370-n/a</pages><issn>0146-6615</issn><issn>1096-9071</issn><eissn>1096-9071</eissn><abstract>Human papillomavirus (HPV) is the most common sexually transmitted infection, linked to several types of lesions. HPV, specifically HPV 16, accounts for most of anal cancer cases. In this study, we evaluated the proportion of samples tested positive for HPV and characterized genotypes distribution in anal specimens collected from individuals at risk of anal HPV infection attending from 2018 to 2022 a large Infectious Diseases Department in Italy. The presence of HPV DNA was investigated through a commercial kit detecting 12 HR‐HPV, 8 probable/possible HR‐HPV, and 8 LR‐HPV genotypes. Among 1514 samples, 84% (1266/1514) resulted positive for any type of HPV. The prevalence of high‐risk HPV types remained high during all the years of the study period, from 2018 to 2022, ranging from 65% to 73%. Most of HR‐HPV, LR‐HPV and HPV 16 positive samples were collected from men &gt;45 years. HPV 16 was also the most frequent type in men and women. We did not observe significant variations between years in detection of HR‐HPV, instead of LR‐HPV, that significantly decreased. In conclusion, the high prevalence of oncogenic HPV genotypes underlines the necessity of clear anal HPV screening guidelines and, along with frequent HR‐HPV coinfections, reinforces the urge to intensify the anti‐HPV vaccination campaign.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>38197518</pmid><doi>10.1002/jmv.29370</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0003-3685-4289</orcidid><orcidid>https://orcid.org/0000-0003-0740-5361</orcidid><orcidid>https://orcid.org/0000-0001-5999-006X</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0146-6615
ispartof Journal of medical virology, 2024-01, Vol.96 (1), p.e29370-n/a
issn 0146-6615
1096-9071
1096-9071
language eng
recordid cdi_proquest_miscellaneous_2913081827
source MEDLINE; Access via Wiley Online Library
subjects anal canal
Female
Genotype
Genotypes
HIV
HPV
HPV 16
Human papillomavirus
Human papillomavirus 16
Humans
Infectious diseases
Italy - epidemiology
Male
Medical screening
Papillomavirus Infections - epidemiology
Prevalence
Risk
Sexually transmitted diseases
STD
STI
Vaccination
Virology
title High prevalence of high‐risk HPV genotypes in individuals attending an infectious diseases clinic from 2018 to 2022 in Milan, Italy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-03T00%3A26%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=High%20prevalence%20of%20high%E2%80%90risk%20HPV%20genotypes%20in%20individuals%20attending%20an%20infectious%20diseases%20clinic%20from%202018%20to%202022%20in%20Milan,%20Italy&rft.jtitle=Journal%20of%20medical%20virology&rft.au=Rizzo,%20Alberto&rft.date=2024-01&rft.volume=96&rft.issue=1&rft.spage=e29370&rft.epage=n/a&rft.pages=e29370-n/a&rft.issn=0146-6615&rft.eissn=1096-9071&rft_id=info:doi/10.1002/jmv.29370&rft_dat=%3Cproquest_cross%3E2913081827%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2917777697&rft_id=info:pmid/38197518&rfr_iscdi=true